0001209191-23-017704.txt : 20230309
0001209191-23-017704.hdr.sgml : 20230309
20230309210220
ACCESSION NUMBER: 0001209191-23-017704
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230307
FILED AS OF DATE: 20230309
DATE AS OF CHANGE: 20230309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glenning Robert
CENTRAL INDEX KEY: 0001678676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36306
FILM NUMBER: 23721408
MAIL ADDRESS:
STREET 1: C/O EAGLE PHARMACEUTICALS, INC.
STREET 2: 50 TICE BLVD SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000827871
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-326-5300
MAIL ADDRESS:
STREET 1: 50 TICE BOULEVARD, SUITE 315
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19880120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-07
0
0000827871
EAGLE PHARMACEUTICALS, INC.
EGRX
0001678676
Glenning Robert
C/O EAGLE PHARMACEUTICALS, INC.
50 TICE BLVD., SUITE 315
WOODCLIFF LAKE
NJ
07677
1
0
0
0
Stock Option (right to buy)
26.00
2023-03-07
4
A
0
16253
0.00
A
2033-03-07
Common Stock
16253
16253
D
The option fully vests on March 7, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.
/s/ Scott Tarriff, Attorney-in-Fact
2023-03-09